NCT03220854 SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx Status COMPLETED Phase PHASE2
NCT03207672 Study of E7389 Liposomal Formulation in Participants With Solid Tumor Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03195478 A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03182673 The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03182257 Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03181854 Randomized Controlled Trial of Integrated Early Palliative Care Status COMPLETED Phase NA
NCT03168061 Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03166904 Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy Status WITHDRAWN Phase PHASE2
NCT03166176 Phase II Trial of Vistusertib(AZD2014) Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy Status WITHDRAWN Phase PHASE2
NCT03164603 NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03159585 To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors Status COMPLETED Phase PHASE1
NCT03147976 QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors Status WITHDRAWN Phase PHASE2
NCT03139370 Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers Status TERMINATED Phase PHASE1
NCT03130140 MOSE to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions Status COMPLETED Phase NA
NCT03129139 A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT03118817 Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers Status COMPLETED Phase PHASE1
NCT03109639 A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions Status COMPLETED Phase NA
NCT03099109 A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors Status COMPLETED Phase PHASE1